ubiquitin-conjugating enzyme cdc34 inhibitors (Novartis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameubiquitin-conjugating enzyme cdc34 inhibitors (Novartis)
Drug Alias Nameubiquitination pathway inhibitors (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-protein ligases inhibitors
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A